Press Releases

Date	Title	Company
16-Jun-2022	Orthobiologics Market is likely to grow at a CAGR of 3.5% through 2027	MARKITWIRED
16-Jun-2022	Automated CPR Devices Market is slated to grow at approximately 13% CAGR throughout the forecast period by 2031	MARKITWIRED
16-Jun-2022	Hips & Knees Reconstructive Market Competitive Growth Strategies Based on Type, Applications, End User and Region	MARKITWIRED
16-Jun-2022	Biophytis presents preclinical efficacy data for Sarconeos (BIO101) in Spinal Muscular Atrophy (SMA), a rare neuromuscular disease	Biophytis
15-Jun-2022	IGEA Pharma N.V.: IGEA to get SIX further approval to the 2021 annual report disclosure	IGEA Pharma N.V.
15-Jun-2022	PharmaSGP Holding SE successfully holds 2022 AGM	PharmaSGP Holding SE
15-Jun-2022	SK pharmteco announces $35m investment in Phase 1 of new expansion plan for SK biotek Ireland’s Swords Campus	SK pharmteco
15-Jun-2022	Aptamer Group signs deal with Flip Gene Therapeutics to support the development of inducible gene therapies	Aptamer Group
15-Jun-2022	Keensight Capital invests in Cardiff-Based CatSci Ltd	Keensight Capital
15-Jun-2022	BIOWIN, CETIC AND ESSENSCIA WALLONIE LAUNCH BIOMAN INITIATIVE TO ACCELERATE DIGITIZATION OF BIOPROCESSES IN WALLONIA	BIOWIN
15-Jun-2022	A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity	Newswire
15-Jun-2022	Banook group continues global expansion with US office opening	Andrew Lloyd Associates
15-Jun-2022	Human Growth Hormone Treatment & Drugs Market is Projected to Achieve US$ 4.8 Billion by 2032	MARKITWIRED
15-Jun-2022	Sleep Apnea Devices Market is projected to register a CAGR of 7.8% during the forecast period 2022-2032	MARKITWIRED
15-Jun-2022	Cell Culture Media Market is expected to advance at a CAGR of 16% from 2022 to 2032	MARKITWIRED
15-Jun-2022	Gamma Probe Devices Market is expected to exhibit a CAGR of close to 9.5% over the forecast period by 2031	MARKITWIRED
15-Jun-2022	Diabetic Shoes Market is expected to grow at 6.4% CAGR during the forecast period of 2022-2032	MARKITWIRED
15-Jun-2022	SHIONOGI SIGNS AGREEMENT WITH NHS ENGLAND TO BEGIN AN INNOVATIVE SUBSCRIPTION PAYMENT MODEL FOR REIMBURSEMENT OF ITS ANTIBIOTIC, FETCROJA®▼ (CEFIDEROCOL)	Shionogi
15-Jun-2022	CatSci Receive Significant Investment from Keensight Capital	CatSci Ltd
15-Jun-2022	Orion Acquires Inovet’s Animal Health Business	Orion Corporation